【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Overview of cancer
• Epidemiology
• Economic burden of cancer
PART 06: Biosimilars industry
• Comparison between biosimilars and generic small molecules
• Factors influencing biologics and biosimilars
• Biosimilars: business and pricing strategy
• Factors affecting the uptake of biosimilars
• Biosimilar opportunities
• Growth of biosimilars 2014– 2020
• Market penetration of originators and biosimilars in different regions
• Current and future trends in global oncology biosimilars market
• Challenges for new entrants
PART 07: Global pharmaceutical market
• Market size and forecast
• Global biosimilars market
PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 09: Market segmentation by end-user
• Hospitals
• Retail pharmacies
PART 10: Market segmentation by application
• Cancer treatment drugs
• Supportive care drugs
PART 11: Geographical segmentation
• Global oncology biosimilar drugs market by geographical segmentation 2015-2020
• Oncology biosimilars market in EMEA
• Oncology biosimilars market in APAC
• Oncology biosimilars market in Americas
PART 12: Key leading regions
• US
• Europe
• Japan
• India
• China
PART 13: Market drivers
• Rise in number of patent expiries
• Increase in prevalence of cancer
• Growing aging population
• Promising drug pipeline
• Need for cost-effective treatment
• Favorable government regulations
PART 14: Impact of drivers
PART 15: Market challenges
• Risks related to failure of drugs in market
• Multiple manufacturing complexities
• Reluctance among physicians to prescribe biosimilar products
• Complicated regulatory process
• Limited availability of biosimilar products
• Risk of side effects
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Emergence of biosimilars
• Outsourcing of biosimilar manufacturing activities
• Rising number of strategic collaborations
• Increase in cancer awareness
• Rise in R&D
PART 18: Vendor landscape
• Competitive scenario
• Biocon
• Celltrion
• Dr. Reddy’s Laboratories
• F Hoffmann-La Roche
• Hospira
• Mylan
• Sandoz
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Global biosimilars and oncology biosimilars market 2015
Exhibit 03: Cancer burden in European Union (EU)
Exhibit 04: Global incidence of cancer 2015
Exhibit 05: Global mortality of cancer type 2015
Exhibit 06: Estimated numbers of cancer survivors by age in US 2014
Exhibit 07: Definition of biosimilars in different regions
Exhibit 08: Comparison between biosimilars and generic small molecules
Exhibit 09: Factors influencing biologics and biosimilars
Exhibit 10: Impact of biosimilars cost savings on various sectors
Exhibit 11: Factors affecting success of biosimilars
Exhibit 12: Biosimilars industry: Point-of-view
Exhibit 13: Factors affecting the uptake of biosimilars
Exhibit 14: Strategic factors for new entrant
Exhibit 15: Growth of biosimilars
Exhibit 16: Share of biosimilars in recombinant drugs sales in major markets 2014
Exhibit 17: Trends in global oncology biosimilars market
Exhibit 18: Challenges for new entrants
Exhibit 19: Global pharmaceutical market 2015-2020 ($ trillions)
Exhibit 20: Global biosimilars market 2015-2020 ($ billions)
Exhibit 21: Number of approved biosimilars in regulated and semi-regulated markets
Exhibit 22: Global pharmaceutical, biosimilars, and oncology biosimilars market 2015 ($ billions)
Exhibit 23: Global oncology biosimilars market 2015-2020 ($ billions)
Exhibit 24: Global oncology biosimilars market overview
Exhibit 25: Five forces analysis
Exhibit 26: Oncology biosimilars market segmentation by end-user 2014
Exhibit 27: Global oncology biosimilars segmentation by application
Exhibit 28: Oncology biosimilars by application
Exhibit 29: Global oncology biosimilars market by geographical segmentation 2015
Exhibit 30: Global oncology biosimilars market revenue by geography 2015-2020 ($ billions)
Exhibit 31: Oncology biosimilars market in EMEA 2015-2020 ($ billions)
Exhibit 32: Oncology biosimilars market in APAC 2015-2020 ($ billions)
Exhibit 33: Oncology biosimilars market in Americas 2015-2020 ($ billions)
Exhibit 34: Global oncology biosimilars market: YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 35: Key leading regions
Exhibit 36: Pharmaceutical R&D expenditure in US 2010-2015 ($ billions)
Exhibit 37: Approvals of biologicals versus biosimilars via PHSA
Exhibit 38: Approval process for biosimilars in US
Exhibit 39: Benefits of biosimilars to US healthcare system
Exhibit 40: Role of stake holders
Exhibit 41: SWOT analysis
Exhibit 42: Oncology biosimilars approved by EMA in Europe
Exhibit 43: Guidelines for biosimilars in EU
Exhibit 44: Time line of biosimilars in Europe
Exhibit 45: Key stake holders
Exhibit 46: Key drivers and restraints
Exhibit 47: Biosimilar industry challenges in Europe
Exhibit 48: SWOT analysis
Exhibit 49: Biosimilars approved by PMDA in Japan
Exhibit 50: Review process for biosimilars in Japan
Exhibit 51: Drivers and challenges in oncology biosimilars market in Japan
Exhibit 52: SWOT analysis
Exhibit 53: Biosimilars approved in India
Exhibit 54: Timeline for development of biosimilars in India
Exhibit 55: Challenges and strategies
Exhibit 56: Major domestic and international vendors operating in India
Exhibit 57: Drivers and challenges
Exhibit 58: SWOT analysis
Exhibit 59: Top domestic and international vendors operating in China
Exhibit 60: Drivers and challenges
Exhibit 61: SWOT analysis
Exhibit 62: Patent expiries of oncology biologics in US and EU 2020
Exhibit 63: Global incidence of cancer 2015 and 2020
Exhibit 64: Impact of drivers
Exhibit 65: Impact of drivers and challenges
Exhibit 66: Global competitive landscape 2015
Exhibit 67: Biocon: Key takeaways
Exhibit 68: Celltrion: Key takeaways
Exhibit 69: Dr. Reddy’s Laboratories: Key takeaways
Exhibit 70: F. Hoffmann-La: Key takeaways
Exhibit 71: Hospira: Key takeaways
Exhibit 72: Mylan: Key takeaways
Exhibit 73: Sandoz: Key takeaways
【レポート販売概要】
■ タイトル：腫瘍用バイオ後続品の世界市場：がん治療薬、支持療法用薬■ 英文：Global Oncology Biosimilars Market 2016-2020
■ 発行日：2016年2月17日
■ 調査会社：Technavio
■ 商品コード：IRTNTR8749
■ 調査対象地域：グローバル
- ポテトピーラー/ポテトスライサーの世界市場2017-2021About Potato Peeler and Slicer Equipment Potato processing equipment is sold to end-users in the commercial and industrial setups. During the forecast period, the market is expected to grow mainly due to the increasing replacement demand from developed economies, increase in the number of foodservice establishments, and rising demand for new units of potato peeler and slicer equipment from emergin …
- 女性医療診断の世界市場ABSTRACTAbout Women's Health Diagnostics Technological advances such as integration of digital technology with diagnostic instrumentation, multiple technologies-based hematology analyzers, and quick monitoring of blood flow in deep tissues with real-time software correlators are boosting the growth of the IVD instruments market. The growing popularity of automation and technological advances have …
- 世界のナノ衛星及びマイクロ衛星市場動向及び予測(2014 – 2019)The Nano and Microsatellite market report constitutes of revenues from hardware, software and services required for the development and launch of such satellites. Overall market size is found by adding up the market size for two segments of satellites; namely 1kg to 10kgs (Nano satellites) and 11kgs to 100kgs (Microsatellites). Though above two markets can exist independently, but the playing fiel …
- デジタルコンテンツの世界市場2019-2023133 Pages, November 2018 About this market Digital content service platforms are used by customers to obtain high-quality content. And it is becoming mandatory for digital content vendors to make the content meaningful, informative, and relevant. They also add various popular titles to the content libraries to boost the user experience and satisfaction levels. Technavio’s analysts have predicted t …
- ヨウ化エコチオフェートの世界市場Echothiophate Iodide (CAS 513-10-0) Market Research Report 2014 presents comprehensive data on echothiophate Iodide markets globally and regionally (Europe, Asia, North America etc.) The report includes echothiophate Iodide description, covers its application areas and related patterns. It overviews echothiophate Iodide market, names echothiophate Iodide producers and indicates its suppliers. Besi …
- French Flow Cytometry Market 2014: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive LandscapeComplete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the French flow cytometry market, including:Major issues pertaining to the French flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year …
- 眼瞼炎治療薬の世界市場：ステロイド、抗生物質Global Blepharitis Drugs Market: About this market Blepharitis drugs include steroids and antibiotics, which are used to treat inflammation in the eyelids and infection. Technavio’s blepharitis drugs market analysis considers sales from the steroids and antibiotics segments. Our analysis also considers the sales of blepharitis drugs in Asia, Europe, North America, and ROW. In 2018, the steroids se …
- 光線治療用装置の世界市場予測：ロングランプ、CFL、LED、光ファイバーThe phototherapy equipment market is expected to reach USD 583.4 Million by 2021 from USD 468.2 Million in 2016, growing at a CAGR of 4.5% during the forecast period of 2016 and 2021. This market is primarily driven by the rising incidence of neonatal jaundice in both developed and developing markets, rising number of people suffering from skin diseases, inflow of technologically advanced products …
- Ivoclar Vivadent AG：市場シェア分析Ivoclar Vivadent AG Market Share Analysis Summary GlobalData’s new report, “Ivoclar Vivadent AG Market Share Analysis” provides in-depth information on Ivoclar Vivadent AG’s market position in the different medical equipment markets it operates in. The report provides Ivoclar Vivadent AG market share information in two key market categories – Crowns and Bridges and Dental Lasers. The report also p …
- 世界のワイン市場のM&A動向（2014年7月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global wine market during July 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global wine market throughout the month. Additionally, the report provides an overview of all the partnering, allia …
- 製造産業におけるビックデータ市場：主要動向、市場機会、市場予測The manufacturing industry is rapidly transforming as technology, competition, and the evolving demands of global consumers dictate the need for continuously improving efficiencies and flexibility. Significant impact from ICT include machine communications, teleoperation, and integration with the Internet of Things (IoT). It is anticipated that machine data will represent up to 8 Zeta bytes by 202 …
- インドのハイブリッド種子市場2016-2020About Hybrid Seeds Hybrid seeds, also called F1 hybrid, are produced by controlled cross-pollination between different varieties of the same plant. The process enables the production of desirable traits that cannot be achieved by inbreeding. The resulting seeds produce plants with specific characteristics such as better adaptation to environmental stress factors, more resistance to diseases and pe …
- Second Wave Petroleum Inc.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Second Wave Petroleum Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Second Wave Petroleum Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
- 医療レポート：Endometriosis-疫学予測（～2022）EpiCast Report: Endometriosis - Epidemiology Forecast to 2022 Summary Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. Globally, the disease affects up …
- ヒドロタルシトの世界市場Hydrotalcite (CAS 12304-65-3) Market Research Report 2013 presents comprehensive data on hydrotalcite markets globally and regionally (Europe, Asia, North America etc.) The Hydrotalcite (CAS 12304-65-3) Market Research Report 2013 includes hydrotalcite description, covers its application areas and related patterns. It overviews hydrotalcite market, names hydrotalcite producers and indicates its su …
